GoodRx operates a digital platform that lets consumers compare and save on prescription medication prices. GDRX reports earnings on Tue, Nov 3, 2026. Analyst consensus is Buy, based on the latest ratings from 5 firms (3 buy, 1 hold, 1 sell).
Prices, price targets and earnings estimates for GDRX are shown to AI Starter and AI Pro members. Ratings, flow and news are open to everyone.See plansSign in
No whale options trades in GDRX in the last 90 days.
Total alerts
0
Bullish
0
0%
Bearish
0
0%
Date span
—
Loading…
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GDRX is in one of them and how their past GDRX trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About GoodRx Holdings
GoodRx is a digital healthcare platform based in Santa Monica, California, that helps Americans find and pay less for prescription medications. Consumers can compare prescription prices across pharmacies and use discount codes for free, or pay a subscription for lower prices and added services such as telehealth visits and mail delivery. The company also offers tools for healthcare providers and sells advertising and affordability programs to pharma manufacturers. Its customers include consumers, physicians, pharmacy benefit managers, pharmacies and drug makers.
